| Financial Year |
March 31 2023 |
| Monetary Funds |
4,272,947,312.75 |
| Held-for-trading Financial Assets |
1,298,869,459.06 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,413,957,613.80 |
| Advances to Suppliers |
391,101,935.29 |
| Other Receivables |
116,977,023.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,980,089,022.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
340,121,559.72 |
| Total Current Assets |
10,993,706,048.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
170,678,795.38 |
| Investment Properties |
269,232.98 |
| Fixed Assetes |
1,072,087,041.13 |
| Under-construction Projects |
398,521,648.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
194,630,219.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
32,770,772.72 |
| Deferred Income Tax Assets |
196,925,951.80 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,478,468,910.78 |
| Total Assets |
13,472,174,959.33 |
| Short-Term Loans |
1,311,349,444.45 |
| Trading Financial liabilities |
2,851,205.01 |
| Notes Payable |
307,277,466.56 |
| Accounts Payable |
2,403,071,549.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
67,709,493.22 |
| Taxes Payable |
141,116,152.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
969,893,203.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,057,541.21 |
| Other Current Liabilities |
85,595,653.58 |
| Sub-Total of Current Liabilities |
5,633,998,969.25 |
| Long-term Loans |
-- |
| Bonds Payable |
966,173,073.81 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
62,297,233.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,087,876,859.19 |
| Total Liabilities |
6,721,875,828.44 |
| Paid-In Capital(Or Share Stock) |
572,398,342.00 |
| Capital Surplus |
1,653,729,430.70 |
| Surplus Reserve |
225,333,101.75 |
| LESS:Treasury Stock |
334,174,207.26 |
| Undistributed Profits |
4,521,393,116.41 |
| Minority Stockholder's Interest |
1,028,501.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,749,270,629.60 |
| Owner's Equity（Stockholder's Equity） |
6,750,299,130.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,472,174,959.33 |
